Skip to main
NEOG

Neogen (NEOG) Stock Forecast & Price Target

Neogen (NEOG) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Neogen Corporation's robust position in the food and animal safety sectors is underscored by its commitment to innovation and product development, which strengthens its competitive edge in diagnostics and veterinary products. The company has effectively increased its market presence through strategic acquisitions, enhancing its ability to respond to growing demand in food safety and animal health markets. Despite potential risks such as supply chain disruptions and reliance on internal growth, Neogen's diversified product offerings and recent expansion efforts contribute to a favorable long-term outlook.

Bears say

Neogen Corporation's focus on food and animal safety encompasses a broad range of diagnostics and products aimed at preventing contamination and ensuring health standards, yet its financial performance has raised concerns, particularly regarding revenue growth and profitability margins. Recent financial reports indicate stagnation or decline in key revenue metrics, which may be indicative of increasing competition and pricing pressures within the industry. Additionally, potential regulatory challenges and rising operational costs further exacerbate the company's financial vulnerabilities, contributing to a negative outlook for Neogen's stock prospects.

Neogen (NEOG) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Neogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Neogen (NEOG) Forecast

Analysts have given Neogen (NEOG) a Buy based on their latest research and market trends.

According to 3 analysts, Neogen (NEOG) has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Neogen (NEOG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.